60 Degrees Pharmaceuticals, Inc. (SXTPW) stock
SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value
$0.03−0.00 (-0.38%)
Close on Oct 30, 2026Market cap $3.31MP/E –Yield –
60 Degrees Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
60 Degrees Pharmaceuticals's cash was $1.02M at Jun 30, 2026. For fiscal 2025 it was $2.75M, down 18.8% from the year before. The highest annual figure on record is $3.39M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.75M | -18.8% |
| FY2024 | Dec 31, 2024 | $3.39M | +58.1% |
| FY2023 | Dec 31, 2023 | $2.14M | +708.9% |
| FY2022 | Dec 31, 2022 | $264.87K | +129.5% |
| FY2021 | Dec 31, 2021 | $115.40K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.02M | -48.0% |
| Q1 FY2026 | Mar 31, 2026 | $3.34M | -3.3% |
| Q4 FY2025 | Dec 31, 2025 | $2.75M | -18.8% |
| Q3 FY2025 | Sep 30, 2025 | $4.12M | -17.9% |
| Q2 FY2025 | Jun 30, 2025 | $1.97M | +24.8% |
| Q1 FY2025 | Mar 31, 2025 | $3.45M | +19.2% |
| Q4 FY2024 | Dec 31, 2024 | $3.39M | +58.1% |
| Q3 FY2024 | Sep 30, 2024 | $5.01M | +125.9% |
| Q2 FY2024 | Jun 30, 2024 | $1.58M | +8167.4% |
| Q1 FY2024 | Mar 31, 2024 | $2.89M | +9551.3% |
| Q4 FY2023 | Dec 31, 2023 | $2.14M | +708.9% |
| Q3 FY2023 | Sep 30, 2023 | $2.22M | +404.9% |
| Q2 FY2023 | Jun 30, 2023 | $19.07K | -97.5% |
| Q1 FY2023 | Mar 31, 2023 | $29.99K | -74.0% |
| Q4 FY2022 | Dec 31, 2022 | $264.87K | – |
| Q3 FY2022 | Sep 30, 2022 | $439.39K | – |
| Q2 FY2022 | Jun 30, 2022 | $751.45K | – |
| Q4 FY2021 | Dec 31, 2021 | $115.40K | – |